Hyperammonemia in lung transplantation: recognizing the gaps of our knowledge

Affiliations

¹ Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
² Department of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, USA.

Editorial

Jessica M Lum et al. Transpl Infect Dis. 2022 Dec.

. 2022 Dec;24(6):e13937.

doi: 10.1111/tid.13937. Epub 2022 Sep 6.

¹ Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
² Department of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, USA.

No abstract available

Keywords: Ureaplasma; donor-derived infection; hyperammonemia syndrome; lung transplantation.

References

1. Bharat A, Cunningham SA, Scott Budinger GR, et al. Disseminated ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med. 2015;7(284):284re3.
1. Buzo BF, Preiksaitis JK, Halloran K, et al. Hyperammonemia syndrome post-lung transplantation: case series and systematic review of the literature. Transpl Infect Dis. 2022;35:10433.
1. Fernandez R, Ratliff A, Crabb D, Waites KB, Bharat A. Ureaplasma transmitted from donor lungs is pathogenic after lung transplantation. Ann Thorac Surg. 2017;103(2):670-671.
1. Buzo BF, Preiksaitis JK, Halloran K, et al. Association between mycoplasma and ureaplasma airway positivity, ammonia levels, and outcomes post-lung transplantation: a prospective surveillance study. Am J Transplant. 2021;21(6):2123-2131.
1. Roberts SC, Bharat A, Kurihara C, Tomic R, Ison MG. Impact of screening and treatment of ureaplasma species on hyperammonemia syndrome in lung transplant recipients: a single center experience. Clin Infect Dis. 2021;73(9):e2531-e2537.